The plan of this proposal is to study interactions between factors that have been implicated in ocular neovascularization-vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1 (HIF-1), angiopoietin 2 (Ang2), and insulin-like growth factor (IGF-1). The plan is to use both transgenic and gene transfer approaches to test the following hypotheses: 1) Increased expression of VEGF in the inner retina will result in retinal neovascularization from the deep capillary bed but not the superficial capillaries as occurs in ischemic retinopathies. 2) Increased expression of HIF-1alpha will more closely mimic ishemic retinopathy because it upregulates other factors in addition to VEGF. 3) Increased production of IGF-1 in the inner retina will not be sufficient to produce retinal neovascularization, but will enhance the effects of VEGF. 4) Increased expression of VEGF in retinal pigment epithelial cells (RPE) is sufficient to cause choroidal neovascularization. 5) Increased expression of Ang2 in the retina causes regression of neovascularization, while coexpression of Ang2 and VEGF promotes neovascularization.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY012609-06
Application #
6721137
Study Section
Special Emphasis Panel (ZRG1-SSS-R (02))
Program Officer
Dudley, Peter A
Project Start
1999-01-01
Project End
2005-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
6
Fiscal Year
2004
Total Cost
$286,125
Indirect Cost
Name
Johns Hopkins University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zeng, Mingbing; Shen, Jikui; Liu, Yuanyuan et al. (2017) The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization. J Mol Med (Berl) 95:417-429
Campochiaro, Peter A (2015) Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 49:67-81
Shen, Jikui; Frye, Maike; Lee, Bonnie L et al. (2014) Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest 124:4564-76
Dong, Aling; Seidel, Christopher; Snell, Daniel et al. (2014) Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis 17:553-62
Shen, Jikui; Choy, David F; Yoshida, Tsunehiko et al. (2014) Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. J Cell Physiol 229:974-83
Iwase, Takeshi; Fu, Jie; Yoshida, Tsunehiko et al. (2013) Sustained delivery of a HIF-1 antagonist for ocular neovascularization. J Control Release 172:625-33
Shmueli, Ron B; Ohnaka, Masayuki; Miki, Akiko et al. (2013) Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. Biomaterials 34:7544-51
Iwase, Takeshi; Oveson, Brian C; Hashida, Noriyasu et al. (2013) Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit. Invest Ophthalmol Vis Sci 54:503-11
Campochiaro, Peter A (2013) Ocular neovascularization. J Mol Med (Berl) 91:311-21
Campochiaro, P A (2012) Gene transfer for ocular neovascularization and macular edema. Gene Ther 19:121-6

Showing the most recent 10 out of 83 publications